5-Methylmethiopropamine
Legal status | |
---|---|
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C9H15NS |
Molar mass | 169.29 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
5-Methylmethiopropamine (5-MMPA, mephedrene) is a stimulant drug which is a ring-substituted derivative of methiopropamine. It is not a substituted cathinone derivative like mephedrone, as it lacks a ketone group at the β position of the aliphatic side chain, but instead more closely resembles substituted amphetamines. It has been sold as a designer drug, first being identified in Germany in June 2020.[1][2][3]
See also
- 3-Chloromethamphetamine
- 3-Methylamphetamine
- 3-Methylmethcathinone
- 5-Cl-bk-MPA
References
- ↑ "EU Early Warning System Situation Report. Situation report 2". European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 10 August 2020.
{{cite web}}
: Missing or empty|url=
(help) - ↑ "Info" (PDF). www.aekwien.at. Retrieved 2021-05-13.
- ↑ New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. European Monitoring Center for Drugs and Drug Addiction, December 2020
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.